Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Metabolic regulation of prostate cancer heterogeneity and plasticity.
Semin. Cancer Biol. 82, 94-119 (2022)
Metabolic reprogramming is one of the main hallmarks of cancer cells. It refers to the metabolic adaptations of tumor cells in response to nutrient deficiency, microenvironmental insults, and anti-cancer therapies. Metabolic transformation during tumor development plays a critical role in the continued tumor growth and progression and is driven by a complex interplay between the tumor mutational landscape, epigenetic modifications, and microenvironmental influences. Understanding the tumor metabolic vulnerabilities might open novel diagnostic and therapeutic approaches with the potential to improve the efficacy of current tumor treatments. Prostate cancer is a highly heterogeneous disease harboring different mutations and tumor cell phenotypes. While the increase of intra-tumor genetic and epigenetic heterogeneity is associated with tumor progression, less is known about metabolic regulation of prostate cancer cell heterogeneity and plasticity. This review summarizes the central metabolic adaptations in prostate tumors, state-of-the-art technologies for metabolic analysis, and the perspectives for metabolic targeting and diagnostic implications.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Cancer Stem Cells ; Circulating Tumor Cells ; Disseminated Tumor Cells ; Metabolic Biomarkers ; Metabolic Heterogeneity ; Metabolic Reprogramming ; Metabolic Therapies ; Metabolomics ; Prostate Cancer
ISSN (print) / ISBN
1044-579X
e-ISSN
1096-3650
Zeitschrift
Seminars in Cancer Biology
Quellenangaben
Band: 82,
Seiten: 94-119
Verlag
Saunders
Verlagsort
Philadelphia, Pa.
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute for Pancreatic Beta Cell Research (IPI)